Agilent Technologies Inc.
Agilent Appoints Adam S. Elinoff as New Chief Financial Officer
Summary
Agilent Technologies, Inc. announced on October 23, 2025, the appointment of Adam S. Elinoff as its new Chief Financial Officer, effective November 17, 2025. Mr. Elinoff, previously with Amgen Inc., brings over two decades of experience in finance, strategy, and business transformation. His compensation package includes a base salary of $700,000, eligibility for an annual bonus up to 80% of his base salary, restricted stock units (RSUs) and performance-based RSUs, a one-time cash bonus of $800,000, and a one-time sign-on grant of RSUs and performance-based RSUs. Rodney Gonsalves, the interim CFO, will continue in his role as Vice President, Corporate Controller, and Principal Accounting Officer.
Profitelligence Alerts
Get alerts for A
Be first to know when Agilent Technologies Inc. files with the SEC.
Filing Categories
Exhibits (1)
Advertisement
About Agilent Technologies Inc.
Agilent Technologies Inc. is a global leader in the development and provision of life sciences, diagnostics, and applied chemical markets. Primarily focused on delivering superior analytical instruments, software, services, consumables, and reagents, the company plays a critical role in supporting the research needs of pharmaceutical, biotechnology, and government laboratories. Agilent's robust portfolio includes innovative solutions for genomics, proteomics, and metabolomics, aiding in critical areas such as disease research, food safety, and environmental analysis. Established in 1999 as a spin-off from Hewlett-Packard, the company leverages its heritage of technological innovation to enhance analytical capabilities for its clients. Agilent's significant contributions to health and safety applications underscore its importance in advancing scientific understanding and supporting public health initiatives worldwide.
Official SEC Documents
Advertisement